CD101 and B-cell non-Hodgkin lymphoma: In canine, it has been reported that CD44v3, v6 and v7 mRNAs are expressed in B‐cell lymphoma, and the expression of these mRNAs is associated with chemo‐resistance and a poor prognosis (Motegi et al., 2018).